Lysine Targeting Group‐Transfer Chimeras for Proximity Induction
Abstract
Abstract Nature employs post‐translational modifications (PTMs) to induce proximity between proteins by engendering new interactions. Furthermore, we find that protein ligands are invariably proximal to a lysine. Inspired by these two observations, we developed group‐transfer chimeras (GRCs) that append a moiety‐of‐interest to the lysine side chain. GRCs employ a protein's ligand and a handle with a transferase ‐type reactivity to modify the proximal lysine. Contemporary lysine‐targeting group‐transfer handles were incompatible with GRCs due to their hydrolytic instability, large size, high reactivity, and synthetic incompatibility with diverse ligands. Accordingly, we developed an N ‐( su lfonyl)‐ N ‐(tri f luoroethyl)‐ethan a mide (SuFA) handle that is stable, small, and exhibits tunable reactivity and synthetic compatibility with diverse ligands and proteins. Using GRCs that group‐transfer binders of tags (e.g., HaloTag, FKBP) onto proteins overexpressed in cancer cells, we displayed these binders on the surface of the cancer cell. With a un iversal T cell e ngager (UniTE) that binds to the displayed ligands and T cells, these GRCs induced proximity between cancer cells and cytotoxic T cells, leading to the latter's activation. We envision the GRC platform to find utility in basic research and biomedicine.
Article Details
Authors (17)
Sameek Singh
Chemical Biology and Therapeutics Science
Kien Tran
Chemical Biology and Therapeutics Science
Endri Karaj
Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA
Basudeb Mondal
Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA
Wenzhi Tian
Chemical Biology and Therapeutics Science
Surached Siriwongsup
Department of Cancer Biology
Shaimaa H. Sindi
Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA
Uttam Dhawa
Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA
Kaushik Pal
Veronika M. Shoba
Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA
Sunny Shi
Chemical Biology and Therapeutics Science Broad Institute of MIT and Harvard Cambridge MA 02142 USA
Anna Lian
Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA 02215 USA
Jody Mou
Department of Cancer Biology Dana‐Farber Cancer Institute Boston MA 02215 USA
Myeonghoon Han
Department of Genetics, Blavatnik Institute, Harvard Medical School
Prashant Singh
Ames National Laboratory
Nicholas F. Polizzi
Amit Choudhary
Chemical Biology and Therapeutics Science